Recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels NCT07282912 Conditions Adenocarcinoma, Adenocarcinoma Of Esophagus, Ampullary Adenocarcinoma, +13 more Locations Smilow Cancer Center — New Haven, Connecticut, United States View Trial Details
Recruiting Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula NCT05116072 Conditions Adenocarcinoma, Adenocarcinoma of the Duodenum, Adenocarcinoma of the Pancreas, +5 more Locations Hop Claude Huriez Chu Lille — Lille, France View Trial Details
Recruiting PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma NCT06813976 Conditions Ampullary Adenocarcinoma Locations CHU Dijon Bourgogne — Dijon, France View Trial Details
Recruiting The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. NCT06068023 Conditions Ampullary Adenocarcinoma Locations Fondazione Poliambulanza — Brescia, BS, Italy View Trial Details
Completed Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors NCT04400357 Conditions Adenocarcinoma, Ampullary Adenocarcinoma, Carcinoma, +26 more Locations Ruijin Hospital Shanghai Jiaotong University School of Medicine — Shanghai, Shanghai Municipality, China View Trial Details
